Wei-Jian Ni (Weijian Ni)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Cell death & disease

British journal of pharmacology

Journal of cellular and molecular medicine

Science translational medicine

Anhui Provincial Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Anhui Provincial Hospital

China

Pharmacist-in-charge :: Department of Pharmacy

Publications

Nannan Ma, Hao Lu, Ning Li, Wei-Jian Ni, Wenbo Zhang, Qiang Liu, Wenzheng Wu, Shichao Xia, Jiagen Wen, Tao Zhang
CHOP-mediated Gasdermin E expression promotes pyroptosis, inflammation, and mitochondrial damage in renal ischemia-reperfusion injury. Cell death & disease 15 (2) (2024)
Nannan Ma, Hao Lu, Ning Li, Wei-Jian Ni, Wenbo Zhang, Qiang Liu, Wenzheng Wu, Shichao Xia, Jiagen Wen, Tao Zhang
CHOP-mediated Gasdermin E expression promotes pyroptosis, inflammation, and mitochondrial damage in renal ischemia-reperfusion injury. Cell death & disease 15 (2) (2024)
Nannan Ma, Hao Lu, Ning Li, Wei-Jian Ni, Wenbo Zhang, Qiang Liu, Wenzheng Wu, Shichao Xia, Jiagen Wen, Tao Zhang
CHOP-mediated Gasdermin E expression promotes pyroptosis, inflammation, and mitochondrial damage in renal ischemia-reperfusion injury. Cell death & disease 15 (2) (2024)
Nannan Ma, Hao Lu, Ning Li, Wei-Jian Ni, Wenbo Zhang, Qiang Liu, Wenzheng Wu, Shichao Xia, Jiagen Wen, Tao Zhang
CHOP-mediated Gasdermin E expression promotes pyroptosis, inflammation, and mitochondrial damage in renal ischemia-reperfusion injury. Cell death & disease 15 (2) (2024)
Wei-Jian Ni, Hong Zhou, Hao Lu, Nan-Nan Ma, Bing-Bing Hou, Wei Li, Fan-Xu Kong, Ju-Tao Yu, Rui Hou, Juan Jin, Jia-Gen Wen, Tao Zhang, Xiao-Ming Meng
Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism. Clinical and translational medicine 13 (8) (2023)
Jia-Nan Wang, Fang Wang, Jing Ke, Zeng Li, Chuan-Hui Xu, Qin Yang, Xin Chen, Xiao-Yan He, Yuan He, Xiao-Guo Suo, Chao Li, Ju-Tao Yu, Ling Jiang, Wei-Jian Ni, Juan Jin, Ming-Ming Liu, Wei Shao, Chen Yang, Qian Gong, Hai-Yong Chen, Jun Li, Yong-Gui Wu, Xiao-Ming Meng
Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms. Science translational medicine 14 (640) (2022)
Wei-Jian Ni, Hao Lu, Nan-Nan Ma, Bing-Bing Hou, Jing Zeng, Hong Zhou, Wei Shao, Xiao-Ming Meng
RNA N 6 -methyladenosine modifications and potential targeted therapeutic strategies in kidney disease. British journal of pharmacology (2022)
Wei-Jian Ni, Xi-Mei Guan, Jing Zeng, Hong Zhou, Xiao-Ming Meng, Li-Qin Tang
Berberine regulates mesangial cell proliferation and cell cycle to attenuate diabetic nephropathy through the PI3K/Akt/AS160/GLUT1 signalling pathway. Journal of cellular and molecular medicine 26 (4) (2022)
Hong Zhou, Yan Fang, Tao Xu, Wei-Jian Ni, Ai-Zong Shen, Xiao-Ming Meng
Potential therapeutic targets and promising drugs for combating SARS-CoV-2. British journal of pharmacology 177 (14) (2020)

Wei-Jian Ni.css-eqlu8i{font-size:small;padding-left:4px;} (Weijian Ni)

Publication Activity (10 Years)

Top Topics

Top Venues

Wei-Jian Ni (Weijian Ni)